Leila A. Kutteh

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy

Ravi D. Rao, John C. Michalak, Jeff A. Sloan et al. · Cancer · 2007 · 355 citations

Medicine, Pharmacology, Pharmacotherapy +13

Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831

Michele Y. Halyard, Thomas M. Pisansky, Amylou C. Dueck et al. · Journal of Clinical Oncology · 2009 · 186 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial

Kostandinos Sideras, Paul Schaefer, Scott H. Okuno et al. · Mayo Clinic Proceedings · 2006 · 163 citations

Medicine, Oncology, Pharmacology +6

Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial

Edith A. Perez, Amylou C. Dueck, Ann E. McCullough et al. · Journal of Clinical Oncology · 2013 · 107 citations · Full text

Medicine, Molecular Biology, Oncology +17